These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 34381710)

  • 1. m6A Modification: A Double-Edged Sword in Tumor Development.
    Gao R; Ye M; Liu B; Wei M; Ma D; Dong K
    Front Oncol; 2021; 11():679367. PubMed ID: 34381710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA m6A methylation regulators in ovarian cancer.
    Guo J; Zheng J; Zhang H; Tong J
    Cancer Cell Int; 2021 Nov; 21(1):609. PubMed ID: 34794452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
    Pan J; Huang T; Deng Z; Zou C
    Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
    Jayasree PJ; Dutta S; Karemore P; Khandelia P
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis.
    Fu J; Cui X; Zhang X; Cheng M; Li X; Guo Z; Cui X
    Front Genet; 2021; 12():733871. PubMed ID: 34603394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance.
    Jo H; Shim K; Jeoung D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets.
    Chen DH; Zhang JG; Wu CX; Li Q
    Front Cell Dev Biol; 2021; 9():778582. PubMed ID: 35004679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenine RNA modification and cancer.
    Yang J; Chen J; Fei X; Wang X; Wang K
    Oncol Lett; 2020 Aug; 20(2):1504-1512. PubMed ID: 32724392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of N6-methyl-adenosine modification in mammalian embryonic development.
    Li C; Jiang Z; Hao J; Liu D; Hu H; Gao Y; Wang D
    Genet Mol Biol; 2021; 44(2):e20200253. PubMed ID: 33999093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of m6A RNA methylation in cardiovascular disease (Review).
    Qin Y; Li L; Luo E; Hou J; Yan G; Wang D; Qiao Y; Tang C
    Int J Mol Med; 2020 Dec; 46(6):1958-1972. PubMed ID: 33125109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine modification: A potential regulatory mechanism in spinal cord injury.
    Liu D; Fan B; Li J; Sun T; Ma J; Zhou X; Feng S
    Front Cell Neurosci; 2022; 16():989637. PubMed ID: 36212687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of RNA modification N6-methyladenosine in human cancer.
    Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
    Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
    Chen M; Wong CM
    Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions of RNA N
    Zheng X; Gong Y
    Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of RNA N6-Methyladenosine Modification in Male Infertility and Genital System Tumors.
    Liu S; Lao Y; Wang Y; Li R; Fang X; Wang Y; Gao X; Dong Z
    Front Cell Dev Biol; 2021; 9():676364. PubMed ID: 34124065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.
    Liu S; Chen S; Tang C; Zhao Y; Cui W; Jia L; Wang L
    Front Oncol; 2022; 12():970833. PubMed ID: 36226062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.